ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Competent Cells Market Research Report 2026
Published Date: 2026-01-21
|
Report Code: QYRE-Auto-2G9608
Home | Market Reports | Science
Global Competent Cells Market Insights and Forecast to 2028
BUY CHAPTERS

Global Competent Cells Market Research Report 2026

Code: QYRE-Auto-2G9608
Report
2026-01-21
Pages:149
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N V
Origene Technologies
Lucigen
Zymo Research
Bio Rad Laboratories
Bioline
Delphi Genetics
IBA
Cell Applications
BioDynamics Laboratory
Scarab Genomics
GCC Biotech
SMOBIO Technology
Edge BioSystems

Competent Cells Market Size

The global Competent Cells market was valued at US$ 2585 million in 2025 and is anticipated to reach US$ 4837 million by 2032, at a CAGR of 9.5% from 2026 to 2032.

Competent Cells Market

Competent Cells Market

Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Global Competent Cells key players include Beijing TransGen Biotech, Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, etc. Global top four manufacturers hold a share nearly 30%.
North America is the largest market, with a share about 10%, followed by Asia-Pacific and Europe, both have a share about 20 percent.
In terms of product, Chemically Competent Cells is the largest segment, with a share nearly 65%. And in terms of application, the largest application is Protein Expression, followed by Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, etc.
This report delivers a comprehensive overview of the global Competent Cells market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Competent Cells. The Competent Cells market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Competent Cells market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Competent Cells manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Competent Cells Market Report

Report Metric Details
Report Name Competent Cells Market
Accounted market size in 2025 US$ 2585 million
Forecasted market size in 2032 US$ 4837 million
CAGR 9.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Chemically Competent Cells
  • Electrocompetent Cells
Segment by Application
  • Subcloning & Routine Cloning
  • Phage Display Library Construction
  • Toxic/Unstable DNA Cloning
  • High-Throughput Cloning
  • Protein Expression
  • Mutagenesis
  • Single-Stranded DNA Production
  • Bacmid Creation
  • Cre-Lox Recombination (PIR1/PIR2)
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech, New England Biolabs, QIAGEN N.V., OriGene Technologies, Lucigen, Zymo Research, Bio-Rad Laboratories, Bioline, Delphi Genetics, IBA GmBH, Cell Applications, BioDynamics Laboratory, Scarab Genomics, GCC Biotech, SMOBIO Technology, Edge BioSystems
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Competent Cells companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Competent Cells Market growing?

Ans: The Competent Cells Market witnessing a CAGR of 9.5% during the forecast period 2026-2032.

What is the Competent Cells Market size in 2032?

Ans: The Competent Cells Market size in 2032 will be US$ 4837 million.

What is the market share of major companies in Competent Cells Market?

Ans: Global top four manufacturers hold a share nearly 30%.

What is the Competent Cells Market share by type?

Ans: In terms of product, Chemically Competent Cells is the largest segment, with a share nearly 65%.

Who are the main players in the Competent Cells Market report?

Ans: The main players in the Competent Cells Market are Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech, New England Biolabs, QIAGEN N.V., OriGene Technologies, Lucigen, Zymo Research, Bio-Rad Laboratories, Bioline, Delphi Genetics, IBA GmBH, Cell Applications, BioDynamics Laboratory, Scarab Genomics, GCC Biotech, SMOBIO Technology, Edge BioSystems

What are the Application segmentation covered in the Competent Cells Market report?

Ans: The Applications covered in the Competent Cells Market report are Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, High-Throughput Cloning, Protein Expression, Mutagenesis, Single-Stranded DNA Production, Bacmid Creation, Cre-Lox Recombination (PIR1/PIR2)

What are the Type segmentation covered in the Competent Cells Market report?

Ans: The Types covered in the Competent Cells Market report are Chemically Competent Cells, Electrocompetent Cells

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Competent Cells Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Chemically Competent Cells
1.2.3 Electrocompetent Cells
1.3 Market by Application
1.3.1 Global Competent Cells Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Subcloning & Routine Cloning
1.3.3 Phage Display Library Construction
1.3.4 Toxic/Unstable DNA Cloning
1.3.5 High-Throughput Cloning
1.3.6 Protein Expression
1.3.7 Mutagenesis
1.3.8 Single-Stranded DNA Production
1.3.9 Bacmid Creation
1.3.10 Cre-Lox Recombination (PIR1/PIR2)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Competent Cells Market Perspective (2021–2032)
2.2 Global Competent Cells Growth Trends by Region
2.2.1 Global Competent Cells Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Competent Cells Historic Market Size by Region (2021–2026)
2.2.3 Competent Cells Forecasted Market Size by Region (2027–2032)
2.3 Competent Cells Market Dynamics
2.3.1 Competent Cells Industry Trends
2.3.2 Competent Cells Market Drivers
2.3.3 Competent Cells Market Challenges
2.3.4 Competent Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Competent Cells Players by Revenue
3.1.1 Global Top Competent Cells Players by Revenue (2021–2026)
3.1.2 Global Competent Cells Revenue Market Share by Players (2021–2026)
3.2 Global Top Competent Cells Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Competent Cells Revenue
3.4 Global Competent Cells Market Concentration Ratio
3.4.1 Global Competent Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Competent Cells Revenue in 2025
3.5 Global Key Players of Competent Cells Head Offices and Areas Served
3.6 Global Key Players of Competent Cells, Products and Applications
3.7 Global Key Players of Competent Cells, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Competent Cells Breakdown Data by Type
4.1 Global Competent Cells Historic Market Size by Type (2021–2026)
4.2 Global Competent Cells Forecasted Market Size by Type (2027–2032)
5 Competent Cells Breakdown Data by Application
5.1 Global Competent Cells Historic Market Size by Application (2021–2026)
5.2 Global Competent Cells Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Competent Cells Market Size (2021–2032)
6.2 North America Competent Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Competent Cells Market Size by Country (2021–2026)
6.4 North America Competent Cells Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Competent Cells Market Size (2021–2032)
7.2 Europe Competent Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Competent Cells Market Size by Country (2021–2026)
7.4 Europe Competent Cells Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Competent Cells Market Size (2021–2032)
8.2 Asia-Pacific Competent Cells Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Competent Cells Market Size by Region (2021–2026)
8.4 Asia-Pacific Competent Cells Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Competent Cells Market Size (2021–2032)
9.2 Latin America Competent Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Competent Cells Market Size by Country (2021–2026)
9.4 Latin America Competent Cells Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Competent Cells Market Size (2021–2032)
10.2 Middle East & Africa Competent Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Competent Cells Market Size by Country (2021–2026)
10.4 Middle East & Africa Competent Cells Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Competent Cells Introduction
11.1.4 Merck KGaA Revenue in Competent Cells Business (2021–2026)
11.1.5 Merck KGaA Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Competent Cells Introduction
11.2.4 Thermo Fisher Scientific Revenue in Competent Cells Business (2021–2026)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Competent Cells Introduction
11.3.4 Agilent Technologies Revenue in Competent Cells Business (2021–2026)
11.3.5 Agilent Technologies Recent Development
11.4 Takara Bio
11.4.1 Takara Bio Company Details
11.4.2 Takara Bio Business Overview
11.4.3 Takara Bio Competent Cells Introduction
11.4.4 Takara Bio Revenue in Competent Cells Business (2021–2026)
11.4.5 Takara Bio Recent Development
11.5 Promega Corporation
11.5.1 Promega Corporation Company Details
11.5.2 Promega Corporation Business Overview
11.5.3 Promega Corporation Competent Cells Introduction
11.5.4 Promega Corporation Revenue in Competent Cells Business (2021–2026)
11.5.5 Promega Corporation Recent Development
11.6 Beijing TransGen Biotech
11.6.1 Beijing TransGen Biotech Company Details
11.6.2 Beijing TransGen Biotech Business Overview
11.6.3 Beijing TransGen Biotech Competent Cells Introduction
11.6.4 Beijing TransGen Biotech Revenue in Competent Cells Business (2021–2026)
11.6.5 Beijing TransGen Biotech Recent Development
11.7 GeneScript Corporation
11.7.1 GeneScript Corporation Company Details
11.7.2 GeneScript Corporation Business Overview
11.7.3 GeneScript Corporation Competent Cells Introduction
11.7.4 GeneScript Corporation Revenue in Competent Cells Business (2021–2026)
11.7.5 GeneScript Corporation Recent Development
11.8 Yeastern Biotech
11.8.1 Yeastern Biotech Company Details
11.8.2 Yeastern Biotech Business Overview
11.8.3 Yeastern Biotech Competent Cells Introduction
11.8.4 Yeastern Biotech Revenue in Competent Cells Business (2021–2026)
11.8.5 Yeastern Biotech Recent Development
11.9 New England Biolabs
11.9.1 New England Biolabs Company Details
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs Competent Cells Introduction
11.9.4 New England Biolabs Revenue in Competent Cells Business (2021–2026)
11.9.5 New England Biolabs Recent Development
11.10 QIAGEN N.V.
11.10.1 QIAGEN N.V. Company Details
11.10.2 QIAGEN N.V. Business Overview
11.10.3 QIAGEN N.V. Competent Cells Introduction
11.10.4 QIAGEN N.V. Revenue in Competent Cells Business (2021–2026)
11.10.5 QIAGEN N.V. Recent Development
11.11 OriGene Technologies
11.11.1 OriGene Technologies Company Details
11.11.2 OriGene Technologies Business Overview
11.11.3 OriGene Technologies Competent Cells Introduction
11.11.4 OriGene Technologies Revenue in Competent Cells Business (2021–2026)
11.11.5 OriGene Technologies Recent Development
11.12 Lucigen
11.12.1 Lucigen Company Details
11.12.2 Lucigen Business Overview
11.12.3 Lucigen Competent Cells Introduction
11.12.4 Lucigen Revenue in Competent Cells Business (2021–2026)
11.12.5 Lucigen Recent Development
11.13 Zymo Research
11.13.1 Zymo Research Company Details
11.13.2 Zymo Research Business Overview
11.13.3 Zymo Research Competent Cells Introduction
11.13.4 Zymo Research Revenue in Competent Cells Business (2021–2026)
11.13.5 Zymo Research Recent Development
11.14 Bio-Rad Laboratories
11.14.1 Bio-Rad Laboratories Company Details
11.14.2 Bio-Rad Laboratories Business Overview
11.14.3 Bio-Rad Laboratories Competent Cells Introduction
11.14.4 Bio-Rad Laboratories Revenue in Competent Cells Business (2021–2026)
11.14.5 Bio-Rad Laboratories Recent Development
11.15 Bioline
11.15.1 Bioline Company Details
11.15.2 Bioline Business Overview
11.15.3 Bioline Competent Cells Introduction
11.15.4 Bioline Revenue in Competent Cells Business (2021–2026)
11.15.5 Bioline Recent Development
11.16 Delphi Genetics
11.16.1 Delphi Genetics Company Details
11.16.2 Delphi Genetics Business Overview
11.16.3 Delphi Genetics Competent Cells Introduction
11.16.4 Delphi Genetics Revenue in Competent Cells Business (2021–2026)
11.16.5 Delphi Genetics Recent Development
11.17 IBA GmBH
11.17.1 IBA GmBH Company Details
11.17.2 IBA GmBH Business Overview
11.17.3 IBA GmBH Competent Cells Introduction
11.17.4 IBA GmBH Revenue in Competent Cells Business (2021–2026)
11.17.5 IBA GmBH Recent Development
11.18 Cell Applications
11.18.1 Cell Applications Company Details
11.18.2 Cell Applications Business Overview
11.18.3 Cell Applications Competent Cells Introduction
11.18.4 Cell Applications Revenue in Competent Cells Business (2021–2026)
11.18.5 Cell Applications Recent Development
11.19 BioDynamics Laboratory
11.19.1 BioDynamics Laboratory Company Details
11.19.2 BioDynamics Laboratory Business Overview
11.19.3 BioDynamics Laboratory Competent Cells Introduction
11.19.4 BioDynamics Laboratory Revenue in Competent Cells Business (2021–2026)
11.19.5 BioDynamics Laboratory Recent Development
11.20 Scarab Genomics
11.20.1 Scarab Genomics Company Details
11.20.2 Scarab Genomics Business Overview
11.20.3 Scarab Genomics Competent Cells Introduction
11.20.4 Scarab Genomics Revenue in Competent Cells Business (2021–2026)
11.20.5 Scarab Genomics Recent Development
11.21 GCC Biotech
11.21.1 GCC Biotech Company Details
11.21.2 GCC Biotech Business Overview
11.21.3 GCC Biotech Competent Cells Introduction
11.21.4 GCC Biotech Revenue in Competent Cells Business (2021–2026)
11.21.5 GCC Biotech Recent Development
11.22 SMOBIO Technology
11.22.1 SMOBIO Technology Company Details
11.22.2 SMOBIO Technology Business Overview
11.22.3 SMOBIO Technology Competent Cells Introduction
11.22.4 SMOBIO Technology Revenue in Competent Cells Business (2021–2026)
11.22.5 SMOBIO Technology Recent Development
11.23 Edge BioSystems
11.23.1 Edge BioSystems Company Details
11.23.2 Edge BioSystems Business Overview
11.23.3 Edge BioSystems Competent Cells Introduction
11.23.4 Edge BioSystems Revenue in Competent Cells Business (2021–2026)
11.23.5 Edge BioSystems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N V
Origene Technologies
Lucigen
Zymo Research
Bio Rad Laboratories
Bioline
Delphi Genetics
IBA
Cell Applications
BioDynamics Laboratory
Scarab Genomics
GCC Biotech
SMOBIO Technology
Edge BioSystems
List of Tables
 Table 1. Global Competent Cells Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Chemically Competent Cells
 Table 3. Key Players of Electrocompetent Cells
 Table 4. Global Competent Cells Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Competent Cells Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Competent Cells Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Competent Cells Market Share by Region (2021–2026)
 Table 8. Global Competent Cells Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Competent Cells Market Share by Region (2027–2032)
 Table 10. Competent Cells Market Trends
 Table 11. Competent Cells Market Drivers
 Table 12. Competent Cells Market Challenges
 Table 13. Competent Cells Market Restraints
 Table 14. Global Competent Cells Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Competent Cells Market Share by Players (2021–2026)
 Table 16. Global Top Competent Cells Players by Tier (Tier 1, Tier 2, and Tier 3), based on Competent Cells Revenue, 2025
 Table 17. Ranking of Global Top Competent Cells Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Competent Cells Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Competent Cells, Headquarters and Area Served
 Table 20. Global Key Players of Competent Cells, Products and Applications
 Table 21. Global Key Players of Competent Cells, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Competent Cells Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Competent Cells Revenue Market Share by Type (2021–2026)
 Table 25. Global Competent Cells Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Competent Cells Revenue Market Share by Type (2027–2032)
 Table 27. Global Competent Cells Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Competent Cells Revenue Market Share by Application (2021–2026)
 Table 29. Global Competent Cells Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Competent Cells Revenue Market Share by Application (2027–2032)
 Table 31. North America Competent Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Competent Cells Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Competent Cells Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Competent Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Competent Cells Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Competent Cells Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Competent Cells Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Competent Cells Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Competent Cells Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Competent Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Competent Cells Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Competent Cells Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Competent Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Competent Cells Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Competent Cells Market Size by Country (US$ Million), 2027–2032
 Table 46. Merck KGaA Company Details
 Table 47. Merck KGaA Business Overview
 Table 48. Merck KGaA Competent Cells Product
 Table 49. Merck KGaA Revenue in Competent Cells Business (US$ Million), 2021–2026
 Table 50. Merck KGaA Recent Development
 Table 51. Thermo Fisher Scientific Company Details
 Table 52. Thermo Fisher Scientific Business Overview
 Table 53. Thermo Fisher Scientific Competent Cells Product
 Table 54. Thermo Fisher Scientific Revenue in Competent Cells Business (US$ Million), 2021–2026
 Table 55. Thermo Fisher Scientific Recent Development
 Table 56. Agilent Technologies Company Details
 Table 57. Agilent Technologies Business Overview
 Table 58. Agilent Technologies Competent Cells Product
 Table 59. Agilent Technologies Revenue in Competent Cells Business (US$ Million), 2021–2026
 Table 60. Agilent Technologies Recent Development
 Table 61. Takara Bio Company Details
 Table 62. Takara Bio Business Overview
 Table 63. Takara Bio Competent Cells Product
 Table 64. Takara Bio Revenue in Competent Cells Business (US$ Million), 2021–2026
 Table 65. Takara Bio Recent Development
 Table 66. Promega Corporation Company Details
 Table 67. Promega Corporation Business Overview
 Table 68. Promega Corporation Competent Cells Product
 Table 69. Promega Corporation Revenue in Competent Cells Business (US$ Million), 2021–2026
 Table 70. Promega Corporation Recent Development
 Table 71. Beijing TransGen Biotech Company Details
 Table 72. Beijing TransGen Biotech Business Overview
 Table 73. Beijing TransGen Biotech Competent Cells Product
 Table 74. Beijing TransGen Biotech Revenue in Competent Cells Business (US$ Million), 2021–2026
 Table 75. Beijing TransGen Biotech Recent Development
 Table 76. GeneScript Corporation Company Details
 Table 77. GeneScript Corporation Business Overview
 Table 78. GeneScript Corporation Competent Cells Product
 Table 79. GeneScript Corporation Revenue in Competent Cells Business (US$ Million), 2021–2026
 Table 80. GeneScript Corporation Recent Development
 Table 81. Yeastern Biotech Company Details
 Table 82. Yeastern Biotech Business Overview
 Table 83. Yeastern Biotech Competent Cells Product
 Table 84. Yeastern Biotech Revenue in Competent Cells Business (US$ Million), 2021–2026
 Table 85. Yeastern Biotech Recent Development
 Table 86. New England Biolabs Company Details
 Table 87. New England Biolabs Business Overview
 Table 88. New England Biolabs Competent Cells Product
 Table 89. New England Biolabs Revenue in Competent Cells Business (US$ Million), 2021–2026
 Table 90. New England Biolabs Recent Development
 Table 91. QIAGEN N.V. Company Details
 Table 92. QIAGEN N.V. Business Overview
 Table 93. QIAGEN N.V. Competent Cells Product
 Table 94. QIAGEN N.V. Revenue in Competent Cells Business (US$ Million), 2021–2026
 Table 95. QIAGEN N.V. Recent Development
 Table 96. OriGene Technologies Company Details
 Table 97. OriGene Technologies Business Overview
 Table 98. OriGene Technologies Competent Cells Product
 Table 99. OriGene Technologies Revenue in Competent Cells Business (US$ Million), 2021–2026
 Table 100. OriGene Technologies Recent Development
 Table 101. Lucigen Company Details
 Table 102. Lucigen Business Overview
 Table 103. Lucigen Competent Cells Product
 Table 104. Lucigen Revenue in Competent Cells Business (US$ Million), 2021–2026
 Table 105. Lucigen Recent Development
 Table 106. Zymo Research Company Details
 Table 107. Zymo Research Business Overview
 Table 108. Zymo Research Competent Cells Product
 Table 109. Zymo Research Revenue in Competent Cells Business (US$ Million), 2021–2026
 Table 110. Zymo Research Recent Development
 Table 111. Bio-Rad Laboratories Company Details
 Table 112. Bio-Rad Laboratories Business Overview
 Table 113. Bio-Rad Laboratories Competent Cells Product
 Table 114. Bio-Rad Laboratories Revenue in Competent Cells Business (US$ Million), 2021–2026
 Table 115. Bio-Rad Laboratories Recent Development
 Table 116. Bioline Company Details
 Table 117. Bioline Business Overview
 Table 118. Bioline Competent Cells Product
 Table 119. Bioline Revenue in Competent Cells Business (US$ Million), 2021–2026
 Table 120. Bioline Recent Development
 Table 121. Delphi Genetics Company Details
 Table 122. Delphi Genetics Business Overview
 Table 123. Delphi Genetics Competent Cells Product
 Table 124. Delphi Genetics Revenue in Competent Cells Business (US$ Million), 2021–2026
 Table 125. Delphi Genetics Recent Development
 Table 126. IBA GmBH Company Details
 Table 127. IBA GmBH Business Overview
 Table 128. IBA GmBH Competent Cells Product
 Table 129. IBA GmBH Revenue in Competent Cells Business (US$ Million), 2021–2026
 Table 130. IBA GmBH Recent Development
 Table 131. Cell Applications Company Details
 Table 132. Cell Applications Business Overview
 Table 133. Cell Applications Competent Cells Product
 Table 134. Cell Applications Revenue in Competent Cells Business (US$ Million), 2021–2026
 Table 135. Cell Applications Recent Development
 Table 136. BioDynamics Laboratory Company Details
 Table 137. BioDynamics Laboratory Business Overview
 Table 138. BioDynamics Laboratory Competent Cells Product
 Table 139. BioDynamics Laboratory Revenue in Competent Cells Business (US$ Million), 2021–2026
 Table 140. BioDynamics Laboratory Recent Development
 Table 141. Scarab Genomics Company Details
 Table 142. Scarab Genomics Business Overview
 Table 143. Scarab Genomics Competent Cells Product
 Table 144. Scarab Genomics Revenue in Competent Cells Business (US$ Million), 2021–2026
 Table 145. Scarab Genomics Recent Development
 Table 146. GCC Biotech Company Details
 Table 147. GCC Biotech Business Overview
 Table 148. GCC Biotech Competent Cells Product
 Table 149. GCC Biotech Revenue in Competent Cells Business (US$ Million), 2021–2026
 Table 150. GCC Biotech Recent Development
 Table 151. SMOBIO Technology Company Details
 Table 152. SMOBIO Technology Business Overview
 Table 153. SMOBIO Technology Competent Cells Product
 Table 154. SMOBIO Technology Revenue in Competent Cells Business (US$ Million), 2021–2026
 Table 155. SMOBIO Technology Recent Development
 Table 156. Edge BioSystems Company Details
 Table 157. Edge BioSystems Business Overview
 Table 158. Edge BioSystems Competent Cells Product
 Table 159. Edge BioSystems Revenue in Competent Cells Business (US$ Million), 2021–2026
 Table 160. Edge BioSystems Recent Development
 Table 161. Research Programs/Design for This Report
 Table 162. Key Data Information from Secondary Sources
 Table 163. Key Data Information from Primary Sources
 Table 164. Authors List of This Report


List of Figures
 Figure 1. Competent Cells Picture
 Figure 2. Global Competent Cells Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Competent Cells Market Share by Type: 2025 vs 2032
 Figure 4. Chemically Competent Cells Features
 Figure 5. Electrocompetent Cells Features
 Figure 6. Global Competent Cells Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Competent Cells Market Share by Application: 2025 vs 2032
 Figure 8. Subcloning & Routine Cloning Case Studies
 Figure 9. Phage Display Library Construction Case Studies
 Figure 10. Toxic/Unstable DNA Cloning Case Studies
 Figure 11. High-Throughput Cloning Case Studies
 Figure 12. Protein Expression Case Studies
 Figure 13. Mutagenesis Case Studies
 Figure 14. Single-Stranded DNA Production Case Studies
 Figure 15. Bacmid Creation Case Studies
 Figure 16. Cre-Lox Recombination (PIR1/PIR2) Case Studies
 Figure 17. Competent Cells Report Years Considered
 Figure 18. Global Competent Cells Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 19. Global Competent Cells Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 20. Global Competent Cells Market Share by Region: 2025 vs 2032
 Figure 21. Global Competent Cells Market Share by Players in 2025
 Figure 22. Global Competent Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 23. The Top 10 and 5 Players Market Share by Competent Cells Revenue in 2025
 Figure 24. North America Competent Cells Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. North America Competent Cells Market Share by Country (2021–2032)
 Figure 26. United States Competent Cells Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Canada Competent Cells Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Europe Competent Cells Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Europe Competent Cells Market Share by Country (2021–2032)
 Figure 30. Germany Competent Cells Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. France Competent Cells Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. U.K. Competent Cells Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Italy Competent Cells Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Russia Competent Cells Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Ireland Competent Cells Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Asia-Pacific Competent Cells Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Asia-Pacific Competent Cells Market Share by Region (2021–2032)
 Figure 38. China Competent Cells Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Japan Competent Cells Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. South Korea Competent Cells Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Southeast Asia Competent Cells Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. India Competent Cells Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Australia & New Zealand Competent Cells Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Latin America Competent Cells Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Latin America Competent Cells Market Share by Country (2021–2032)
 Figure 46. Mexico Competent Cells Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Brazil Competent Cells Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Middle East & Africa Competent Cells Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Middle East & Africa Competent Cells Market Share by Country (2021–2032)
 Figure 50. Israel Competent Cells Market Size YoY Growth (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Competent Cells Market Size YoY Growth (US$ Million), 2021–2032
 Figure 52. UAE Competent Cells Market Size YoY Growth (US$ Million), 2021–2032
 Figure 53. Merck KGaA Revenue Growth Rate in Competent Cells Business (2021–2026)
 Figure 54. Thermo Fisher Scientific Revenue Growth Rate in Competent Cells Business (2021–2026)
 Figure 55. Agilent Technologies Revenue Growth Rate in Competent Cells Business (2021–2026)
 Figure 56. Takara Bio Revenue Growth Rate in Competent Cells Business (2021–2026)
 Figure 57. Promega Corporation Revenue Growth Rate in Competent Cells Business (2021–2026)
 Figure 58. Beijing TransGen Biotech Revenue Growth Rate in Competent Cells Business (2021–2026)
 Figure 59. GeneScript Corporation Revenue Growth Rate in Competent Cells Business (2021–2026)
 Figure 60. Yeastern Biotech Revenue Growth Rate in Competent Cells Business (2021–2026)
 Figure 61. New England Biolabs Revenue Growth Rate in Competent Cells Business (2021–2026)
 Figure 62. QIAGEN N.V. Revenue Growth Rate in Competent Cells Business (2021–2026)
 Figure 63. OriGene Technologies Revenue Growth Rate in Competent Cells Business (2021–2026)
 Figure 64. Lucigen Revenue Growth Rate in Competent Cells Business (2021–2026)
 Figure 65. Zymo Research Revenue Growth Rate in Competent Cells Business (2021–2026)
 Figure 66. Bio-Rad Laboratories Revenue Growth Rate in Competent Cells Business (2021–2026)
 Figure 67. Bioline Revenue Growth Rate in Competent Cells Business (2021–2026)
 Figure 68. Delphi Genetics Revenue Growth Rate in Competent Cells Business (2021–2026)
 Figure 69. IBA GmBH Revenue Growth Rate in Competent Cells Business (2021–2026)
 Figure 70. Cell Applications Revenue Growth Rate in Competent Cells Business (2021–2026)
 Figure 71. BioDynamics Laboratory Revenue Growth Rate in Competent Cells Business (2021–2026)
 Figure 72. Scarab Genomics Revenue Growth Rate in Competent Cells Business (2021–2026)
 Figure 73. GCC Biotech Revenue Growth Rate in Competent Cells Business (2021–2026)
 Figure 74. SMOBIO Technology Revenue Growth Rate in Competent Cells Business (2021–2026)
 Figure 75. Edge BioSystems Revenue Growth Rate in Competent Cells Business (2021–2026)
 Figure 76. Bottom-up and Top-down Approaches for This Report
 Figure 77. Data Triangulation
 Figure 78. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Electroporation Competent Cells Market Research Report 2024
Global Clone Competent Cell Market Research Report 2024
Global Ready to Use Cell Freezing Medium Market Research Report 2025
Global Program Controlled Cooling Device Market Research Report 2024
Global Dairy Ultra Heat Treatment System Market Research Report 2024
Global Electroporated Competent Cells Market Research Report 2024
Competent Yeast Cells Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chemically Competent Cells Market Research Report 2024
Global E coli Competent Cells Market Research Report 2024
Global DH5α Competent Cells Market Research Report 2024
Competent E coli Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Expression Competent Cells Market Research Report 2024
Global Agrobacterium tumefaciens Competent Cells Market Research Report 2024
Global Competent Cell Preparation Kit Market Research Report 2024
Global Electrocompetent Cells Market Research Report 2024
Global Electrically Heated Constant Temperature Cell Culture Incubator Market Research Report 2024
Global Dairy Ultra High Temperature Treatment System Market Research Report 2024
Global Intelligent Cell Preparation System Market Research Report 2024
Global Bacterial DNA Extraction Kit Market Research Report 2024
Microbiology Electropermeabilization Technology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions